Demand Media Inc. News Headlines

DMD 
$4.43
*  
0.06
1.34%
Get DMD Alerts
*Delayed - data as of Jan. 26, 2015  -  Find a broker to begin trading DMD now
Exchange: NYSE
Industry: Technology
Community Rating:
View:    DMD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
1/22/2015 6:00:00 PM - Zacks.com


Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog
1/15/2015 4:30:00 PM - Zacks.com


Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4%
1/12/2015 12:55:56 PM - Benzinga


Mid-Morning Market Update: Markets Tumble; Shire To Acquire NPS Pharmaceuticals For $5.2 Billion
1/12/2015 11:37:57 AM - Benzinga


PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
12/24/2014 4:10:00 PM - Zacks.com


Pfizer's Duchenne Muscular Dystrophy Drug in Phase II - Analyst Blog
12/18/2014 7:07:00 PM - Zacks.com


Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog
11/26/2014 10:54:00 AM - Zacks.com


Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog
11/25/2014 6:56:00 PM - Zacks.com


Falling Earnings Estimates Signal Weakness Ahead for Demand Media (DMD) - Tale of the Tape
11/25/2014 8:47:00 AM - Zacks.com


Update: Demand Media Reports Q3 Earnings But Is Still An Avoid
11/14/2014 1:46:00 AM - Seeking Alpha


Sarepta Initiates Dosing for Study Evaluating Eteplirsen - Analyst Blog
11/13/2014 5:40:00 PM - Zacks.com


Sarepta Q3 Loss Narrower-Than-Expected, Eteplirsen in Focus - Analyst Blog
11/10/2014 12:40:00 PM - Zacks.com


Will Demand Media (DMD) Surprise This Earnings Season? - Analyst Blog
11/7/2014 3:22:00 PM - Zacks.com


Why Sarepta Therapeutics Inc. Stock Imploded in October
11/7/2014 8:04:06 AM - Motley Fool


Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
10/29/2014 11:28:00 AM - Zacks.com


Sarepta Slumps as Eteplirsen NDA Submission Gets Delayed - Analyst Blog
10/28/2014 1:22:00 PM - Zacks.com


Rightside: The Market Doesn't Realize How Useful GLTDs Are And How Adoption Affects Earnings
10/16/2014 11:28:00 AM - Seeking Alpha


Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog
10/15/2014 12:59:00 PM - Zacks.com


Prosensa Starts Rolling NDA Submission for Drisapersen - Analyst Blog
10/13/2014 4:30:00 PM - Zacks.com


Demand Media: Undervalued Post Spin-Off Based On Q3 And Q4 2014 Estimates
10/10/2014 7:30:00 AM - Seeking Alpha


Prosensa (RNA) Extends Re-Dosing of Drisapersen into Europe - Analyst Blog
10/3/2014 11:50:00 AM - Zacks.com


Rightside - It's Trending On The Wrong Side
9/13/2014 3:41:00 AM - Seeking Alpha


Is A Big Pop Coming In Tech Stocks?
9/2/2014 7:21:00 PM - Seeking Alpha


Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog
8/12/2014 1:49:00 PM - Zacks.com


Update: Demand Media Earnings
8/11/2014 2:12:00 PM - Seeking Alpha